CN110790790A - Continuous preparation method of penem intermediate MAP - Google Patents
Continuous preparation method of penem intermediate MAP Download PDFInfo
- Publication number
- CN110790790A CN110790790A CN201911033478.3A CN201911033478A CN110790790A CN 110790790 A CN110790790 A CN 110790790A CN 201911033478 A CN201911033478 A CN 201911033478A CN 110790790 A CN110790790 A CN 110790790A
- Authority
- CN
- China
- Prior art keywords
- reaction
- continuous reactor
- solution
- crystallization
- phosphate buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HHXMXAQDOUCLDN-RXMQYKEDSA-N penem Chemical compound S1C=CN2C(=O)C[C@H]21 HHXMXAQDOUCLDN-RXMQYKEDSA-N 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims abstract description 118
- 239000003054 catalyst Substances 0.000 claims abstract description 61
- BHIIGRBMZRSDRI-UHFFFAOYSA-N [chloro(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(Cl)OC1=CC=CC=C1 BHIIGRBMZRSDRI-UHFFFAOYSA-N 0.000 claims abstract description 59
- 229910052703 rhodium Inorganic materials 0.000 claims abstract description 56
- 239000010948 rhodium Substances 0.000 claims abstract description 56
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims abstract description 56
- 238000002425 crystallisation Methods 0.000 claims abstract description 54
- 230000008025 crystallization Effects 0.000 claims abstract description 53
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 21
- 238000005886 esterification reaction Methods 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims description 196
- 239000000243 solution Substances 0.000 claims description 129
- 239000007788 liquid Substances 0.000 claims description 80
- 239000000047 product Substances 0.000 claims description 67
- 239000008055 phosphate buffer solution Substances 0.000 claims description 64
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 56
- 239000002994 raw material Substances 0.000 claims description 54
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 47
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 47
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 46
- 230000014759 maintenance of location Effects 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 39
- 238000010791 quenching Methods 0.000 claims description 23
- 230000000171 quenching effect Effects 0.000 claims description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 21
- 238000005192 partition Methods 0.000 claims description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- MGPXPWLEFHPEJQ-ADFJHRIASA-N (4R)-2-diazo-4-[(2R,3S)-3-[(1R)-1-hydroxyethyl]-4-oxoazetidin-2-yl]-4-methyl-5-(4-nitrophenyl)-3-oxopentanoic acid Chemical compound C[C@@H](O)[C@@H]1[C@@H](NC1=O)[C@@](C)(Cc1ccc(cc1)[N+]([O-])=O)C(=O)C(=[N+]=[N-])C(O)=O MGPXPWLEFHPEJQ-ADFJHRIASA-N 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methylcyclopentane Chemical compound CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 238000010924 continuous production Methods 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 8
- 239000000945 filler Substances 0.000 claims description 7
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 6
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 6
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 6
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 6
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 6
- 235000019797 dipotassium phosphate Nutrition 0.000 claims description 6
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 6
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 6
- 235000019800 disodium phosphate Nutrition 0.000 claims description 6
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 6
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 6
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 239000003208 petroleum Substances 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 5
- 238000009826 distribution Methods 0.000 claims description 4
- 239000012263 liquid product Substances 0.000 claims description 4
- 239000000376 reactant Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 230000032050 esterification Effects 0.000 claims description 2
- 238000005265 energy consumption Methods 0.000 abstract description 7
- FHSUFDYFOHSYHI-UHFFFAOYSA-N 3-oxopentanoic acid Chemical compound CCC(=O)CC(O)=O FHSUFDYFOHSYHI-UHFFFAOYSA-N 0.000 description 17
- 230000003197 catalytic effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 4
- 229960001701 chloroform Drugs 0.000 description 4
- 238000007599 discharging Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 238000002411 thermogravimetry Methods 0.000 description 3
- NFGMWAKGHQALBE-KVGGNSOTSA-N (4-nitrophenyl)methyl (4r,5s,6s)-6-[(1r)-1-hydroxyethyl]-4-methyl-3-[(3s,5s)-1-[(4-nitrophenyl)methoxycarbonyl]-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound N1([C@H](CNS(N)(=O)=O)C[C@@H](C1)SC=1[C@H](C)[C@@H]2[C@H](C(N2C=1C(=O)OCC=1C=CC(=CC=1)[N+]([O-])=O)=O)[C@H](O)C)C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 NFGMWAKGHQALBE-KVGGNSOTSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- FDXUXRZSNNSUGD-NRMKKVEVSA-N (4-nitrophenyl)methyl (4R)-2-diazo-4-[(2R,3S)-3-[(1R)-1-hydroxyethyl]-4-oxoazetidin-2-yl]-3-oxopentanoate Chemical compound N1C(=O)[C@H]([C@H](O)C)[C@H]1[C@@H](C)C(=O)C(=[N+]=[N-])C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 FDXUXRZSNNSUGD-NRMKKVEVSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010062255 Soft tissue infection Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- -1 diphenyloxyphenyl Chemical group 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- MKDJIADBNUOBJH-UHFFFAOYSA-N octanoic acid;rhodium Chemical compound [Rh].[Rh].CCCCCCCC(O)=O.CCCCCCCC(O)=O.CCCCCCCC(O)=O.CCCCCCCC(O)=O MKDJIADBNUOBJH-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- PJGSXYOJTGTZAV-UHFFFAOYSA-N pinacolone Chemical compound CC(=O)C(C)(C)C PJGSXYOJTGTZAV-UHFFFAOYSA-N 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
- B01J31/2208—Oxygen, e.g. acetylacetonates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
- B01J2531/0213—Complexes without C-metal linkages
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/822—Rhodium
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
The invention provides a continuous preparation method of intermediate MAP of penem. The continuous preparation method comprises the following steps: step S1, catalyzing (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl with a rhodium-loaded catalyst in a column type continuous reactor]-3 oxo-pentanoate undergoes a ring closing reaction to form a first intermediate, wherein the supported rhodium catalyst is loaded in the column type continuous reactor, and the supported rhodium catalyst has the following structural formula:step S2, carrying out esterification reaction on the first intermediate, diphenyl chlorophosphate and diisopropylethylamine in a second continuous reactor to obtain a product system containing a penem intermediate MAP; and step S3, carrying out crystallization treatment on the product system to obtain a penem intermediate MAP. Column continuous reactor and rhodium-loaded reactorThe catalyst enables the ring closing reaction to be carried out efficiently at a lower temperature, thereby reducing the energy consumption.
Description
Technical Field
The invention relates to the technical field of preparation of a penem intermediate, and particularly relates to a continuous preparation method of a penem intermediate MAP.
Background
The penem antibiotic, namely the carbapenem antibiotic, belongs to β -lactam antibacterial drugs, has strong antibacterial activity and wide antibacterial spectrum, and is clinically suitable for treating the following moderate and severe infections caused by sensitive bacteria, namely complicated abdominal cavity infection, complicated skin soft tissue infection, community acquired pneumonia, complicated urinary tract infection, acute pelvic cavity infection, serious enterobacteriaceae bacterial infection and the like, so the drug has wide application prospect.
The current industrial scale-up production technology mainly uses batch chemical technology (namely batch reaction production), a solvent, a raw material and a rhodium catalyst are sequentially put into a reaction kettle, the temperature is raised for carrying out a ring closing reaction, the obtained intermediate is cooled and then is sequentially added with diphenyl chlorophosphate and diisopropylethylamine, and the esterification reaction is carried out at a low temperature. The system is subjected to post-treatment operations such as quenching, crystallization and the like to obtain the penem intermediate MAP. The patent application with the application publication number of CN108948086A discloses a process for continuously synthesizing penem antibiotic parent nucleus MAP, wherein methyl tert-butyl ketone is adopted as a solvent to dissolve (3S,4R) -3-, [ 2 ]-1-hydroxyethyl group]-4- [ (1R) -1-methyl-3-diazo-3-p-nitrobenzyloxyformyl-2-one-propyl]-2-azetidinone, using rhodium octanoate dimer as catalyst, carrying out continuous reaction in a first-stage pipeline reactor to prepare intermediate; mixing diphenyl chlorophosphate with N, N-diisopropylethylamine to form a mixture II, cooling the intermediate, and continuously reacting with the mixture II in a secondary pipeline reactorAnd preparing the mother nucleus MAP of the penem antibiotic. However, in the process, the reaction temperature in the primary pipeline reactor is 80-100 ℃ to achieve higher product yield, but the reaction temperature in the secondary pipeline reactor is-25 to-5 ℃, and the temperature difference between the two is large, so that the intermediate needs to be cooled, the energy consumption is high, particularly when the process is amplified to industrial application, the production cost of MAP is high, and the economic benefit of a producer is reduced.
Disclosure of Invention
The invention mainly aims to provide a continuous preparation method of a penem intermediate MAP, which aims to solve the problem of high energy consumption of the continuous preparation process of the penem intermediate MAP in the prior art.
In order to achieve the above object, according to one aspect of the present invention, there is provided a continuous preparation method of intermediate MAP of penem, comprising: step S1, catalyzing (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl with a rhodium-loaded catalyst in a column type continuous reactor]-3 oxo-pentanoate undergoes a ring closing reaction to form a first intermediate, wherein the supported rhodium catalyst is loaded in the column type continuous reactor, and the supported rhodium catalyst has the following structural formula:wherein R is1Represents any one of C1-C10 alkyl; P-COO-represents a residue of the polymer after hydrogen removal, and x represents an arbitrary number of 0.1 to 4.0; step S2, carrying out esterification reaction on the first intermediate, diphenyl chlorophosphate and diisopropylethylamine in a second continuous reactor to obtain a product system containing a penem intermediate MAP; and step S3, carrying out crystallization treatment on the product system to obtain a penem intermediate MAP.
Further, the column type continuous reactor comprises a reaction column, wherein the reaction column comprises a reaction part which is arranged from bottom to top: the feeding section is provided with a liquid inlet, and a liquid distribution device is arranged above the liquid inlet; the reaction section is isolated from the feeding section by a porous bottom plate, inert filler and a rhodium-loaded catalyst are filled in the reaction section, the reaction section is provided with a plurality of first partition plates which are circumferentially arranged, and each first partition plate extends along the vertical direction to divide the inner cavity of the reaction section into a plurality of first reaction chambers; the discharge section is isolated from the reaction section through a porous top plate and is provided with a liquid product outlet and an exhaust port.
Furthermore, a second clapboard is also arranged in the inner cavity of the reaction section, the second clapboard is a cylindrical clapboard which is coaxially arranged with the reaction column, the second clapboard divides the inner cavity of the reaction section into an inner reaction chamber and an outer reaction chamber, and the first clapboard is arranged in the outer reaction chamber and divides the outer reaction chamber into a plurality of first reaction chambers.
Further, in the above structural formula, R1Represents C1-C10 alkyl, preferably methyl, ethyl, tert-butyl, n-hexyl or n-heptyl.
Further, the step S1 includes: dissolving (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3-oxopentanoate in a first organic solvent to form a first raw material solution, the first organic solvent being selected from any one or more of the group consisting of ethyl acetate, methyl acetate, tetrahydrofuran, dichloromethane, chloroform, and methyl isobutyl ketone; feeding the first raw material liquid into a column type continuous reactor, and catalyzing (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3 oxopentanoate to perform a ring-closing reaction at 30-60 ℃ by using a supported rhodium catalyst to form a first intermediate system containing a first intermediate, wherein the retention time of the first raw material liquid in the column type continuous reactor is preferably 2-40 min, and preferably 4-20 min.
Further, the step S2 includes: pre-cooling the second continuous reactor to-32-12 ℃; and (2) respectively feeding the first intermediate system, the diphenyl chlorophosphate solution and the diisopropylethylamine solution into a pre-cooled second continuous reactor for esterification to obtain a product system containing the penem intermediate MAP, wherein a solvent in the diphenyl chlorophosphate solution and a solvent in the diisopropylethylamine solution are respectively and independently selected from any one or more of the group consisting of ethyl acetate, methyl acetate, tetrahydrofuran, dichloromethane, trichloromethane and methyl isobutyl ketone, preferably before the step S2, the first intermediate system obtained in the step S1 is collected into a receiving device and pre-cooled to-12-25 ℃, and the collecting device is connected with the column type continuous reactor and the second continuous reactor.
Further, the second continuous reactor is a one-stage coil continuous reactor or a continuous reactor with multiple stages of coils connected in series, and the retention time of the reactants in the second continuous reactor is 2-40 min, preferably 4-20 min.
Further, the step S3 includes: sending the product system, a quenching agent and a crystallization liquid into a third continuous reactor for continuous crystallization to obtain a crystallization system, wherein the quenching agent is selected from any one or more of pure water, potassium dihydrogen phosphate buffer solution, potassium hydrogen phosphate buffer solution, sodium dihydrogen phosphate buffer solution and sodium hydrogen phosphate buffer solution, and the crystallization liquid is selected from any one or more of hexane, heptane, octane, methylcyclopentane and petroleum ether; and carrying out solid-liquid separation on the crystallization system to obtain the intermediate MAP of the penem.
Further, the third continuous reactor is a one-stage coil continuous reactor or a continuous reactor with a plurality of series-connected coils.
Further, the step S3 includes: sending the product system into a quenching agent for quenching, and then sending a crystallization liquid into the product system for crystallization to obtain a crystallization system, wherein the quenching agent is selected from any one or more of the group consisting of pure water, a potassium dihydrogen phosphate buffer solution, a potassium hydrogen phosphate buffer solution, a sodium dihydrogen phosphate buffer solution and a sodium hydrogen phosphate buffer solution, and the crystallization liquid is selected from any one or more of the group consisting of hexane, heptane, octane, methylcyclopentane and petroleum ether; and carrying out solid-liquid separation on the crystallization system to obtain the intermediate MAP of the penem.
By applying the technical scheme of the invention, the column type continuous reactor is used as a place where the loop closing reaction is generated, and the loop closing reaction forms a gaseous product while forming a first intermediate, and the gaseous product forms a disturbance effect on a loaded rhodium catalyst in the rising process of the gaseous product in the column type continuous reactor, so that the high-efficiency contact of (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3-oxopentanoate ((R) -4-nitrobenzyl 2-diazo-4- ((2R,3S) -3- ((R) -1-hydroxyethaneyl) -4-oxoazetidin-2-yl) -3-oxopentanoate) and the catalyst is facilitated to improve the catalytic effect, in addition, the rhodium-loaded catalyst has higher mechanical property and catalytic activity and is easy to recover due to the fact that the polymer is used as the carrier. Under the synergistic effect of above-mentioned column type continuous reactor and load rhodium catalyst for the ring closing reaction of this application can high-efficiently go on under lower temperature, has reduced the difference in temperature of ring closing reaction and esterification reaction, thereby has reduced the required cold source of first midbody cooling, and then has reduced the energy consumption, is particularly useful for the industrialization and uses.
Drawings
The accompanying drawings, which are incorporated in and constitute a part of this application, illustrate embodiments of the invention and, together with the description, serve to explain the invention and not to limit the invention. In the drawings:
FIG. 1 shows a schematic structural view of a column type continuous reactor employed according to an embodiment of the present invention;
FIG. 2 shows a transverse cross-sectional view of the reaction section of the reaction column of the column-type continuous reactor shown in FIG. 1;
FIG. 3 shows the HPLC profile of the product MAP purity and content test of example 18;
FIG. 4 shows the HPLC profile of the α -isomer test in the product of example 18;
FIG. 5 shows the IR spectrum of MAP in the product of example 18;
FIG. 6 shows a thermogravimetric analysis profile of the product of example 18;
figure 7 shows the XRD spectrum of the product of example 18; and
figure 8 shows the GC spectrum of the solvent residue detection in the product of example 18.
Wherein the figures include the following reference numerals:
11. a feeding section; 111. a liquid inlet; 12. a reaction section; 121. an inert filler; 122. a first separator; 123. a second separator; 13. a discharging section; 131. a liquid product outlet; 132. an exhaust port; 14. a perforated base plate; 15. a perforated top plate.
Detailed Description
It should be noted that the embodiments and features of the embodiments in the present application may be combined with each other without conflict. The present invention will be described in detail below with reference to the embodiments with reference to the attached drawings.
As described in the background of the application, in the prior art, in the process for continuously preparing the intermediate MAP in the penem, a large amount of cold sources are consumed for cooling due to the high temperature of the first-step cyclization reaction, so that the energy consumption is high. In order to solve the problem, the application provides a continuous preparation method of intermediate MAP in penem. In one exemplary embodiment, the continuous production process comprises: step S1, catalyzing (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl with a rhodium-loaded catalyst in a column type continuous reactor]-3 oxo-pentanoate undergoes a ring closing reaction to form a first intermediate, wherein the supported rhodium catalyst is loaded in the column type continuous reactor, and the supported rhodium catalyst has the following structural formula:wherein R is1Represents any one of C1-C10 alkyl; P-COO-represents a residue of the polymer after hydrogen removal, and x represents an arbitrary number of 0.1 to 4.0; step S2, carrying out esterification reaction on the first intermediate, diphenyl chlorophosphate and diisopropylethylamine in a second continuous reactor to obtain a product system containing a penem intermediate MAP; and step S3, carrying out crystallization treatment on the product system to obtain a penem intermediate MAP.
The main reaction formulas of the ring closing reaction and the esterification reaction of the preparation method are as follows:
the method utilizes the column type continuous reactor as a place for loop closing reaction, and the loop closing reaction forms a gaseous product while forming a first intermediate, and the gaseous product forms a disturbance effect on a loaded rhodium catalyst in the rising process of the column type continuous reactor, so that the method is favorable for the efficient contact of (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3-oxopentanoate ((R) -4-nitrobenzyl 2-diaza-4- ((2R,3S) -3- ((R) -1-hydroxyethaneyl) -4-oxoazetidin-2-yl) -3-oxopentanoate) and the catalyst to improve the catalytic effect, in addition, the rhodium-loaded catalyst has higher mechanical property and catalytic activity and is easy to recover due to the fact that the polymer is used as the carrier. Under the synergistic effect of above-mentioned column type continuous reactor and load rhodium catalyst for the ring closing reaction of this application can high-efficiently go on under lower temperature, has reduced the difference in temperature of ring closing reaction and esterification reaction, thereby has reduced the required cold source of first midbody cooling, and then has reduced the energy consumption, is particularly useful for the industrialization and uses.
In a preferred embodiment of the present application, as shown in fig. 1 and 2, the column type continuous reactor comprises a reaction column, the reaction column comprises a feeding section 11, a reaction section 12 and a discharging section 13 arranged from bottom to top, the feeding section 11 is provided with a liquid inlet 111, and a liquid distribution device is arranged above the liquid inlet 111; the reaction section 12 and the feeding section 11 are isolated by a porous bottom plate 14, an inert filler 121 and a loaded rhodium catalyst are filled in the reaction section 12, the reaction section 12 is provided with a plurality of first clapboards 122 which are circumferentially arranged, and each first clapboard 122 extends along the vertical direction to divide the inner cavity of the reaction section 12 into a plurality of first reaction chambers; the discharge section 13 is separated from the reaction section 12 by a porous top plate 15, and the discharge section 13 has a liquid product outlet 131 and an exhaust port 132.
The reaction column of the column type continuous reactor can realize continuous feeding and continuous discharging so as to realize continuous reaction; a liquid distribution device is provided above the liquid inlet 111 so that the reaction physics are fed in a uniform manner; the first partition plate 122 arranged in the reaction section 12 divides the reaction cavity into reaction chambers with small volumes, and the reaction chambers are internally provided with fillers for dispersing the loaded rhodium catalyst arranged therein during the reaction, thereby avoiding the problem of overlarge pressure drop in the reaction column caused by the upward accumulation of the loaded rhodium catalyst driven by the upward flow of the gas by-product; when liquid reaction materials enter each reaction chamber, gaseous byproducts generated by the reaction cannot excessively concentrate to cause transitional impact on the filler and the loaded rhodium catalyst to form large-area cavities because the volume of each reaction chamber is small, and the presence of the filler can further prevent the supported rhodium catalyst from channeling and bypassing due to the impact described above, so that the mass transfer between the liquid phase and the solid phase is uniform in the reaction process, the flow of the gas phase in the liquid phase and the solid phase is also uniform, thereby improving the catalytic efficiency of the rhodium-loaded catalyst, and leading (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3 oxo valerate to be capable of efficiently carrying out the cyclization reaction at a lower temperature.
The feeding section 11, the reaction section 12 and the discharging section 13 of the reaction column can be arranged in the integrally arranged reaction column, and the sections can also be connected through connecting pieces. And the column type continuous reactor can be used in series in multiple stages in order to improve the productivity.
Further, as shown in fig. 2, it is preferable that a second partition plate 123 is further disposed in the inner cavity of the reaction section 12, the second partition plate 123 is a cylindrical partition plate disposed coaxially with the reaction column, the second partition plate 123 partitions the inner cavity of the reaction section 12 into an inner reaction chamber and an outer reaction chamber, and the first partition plate 122 is disposed in the outer reaction chamber and partitions the outer reaction chamber into a plurality of first reaction chambers. The second baffle 123 and the first baffle 122 are combined to further separate the inner cavity of the reaction section 12, so that the mass transfer between the liquid phase and the solid phase is more uniform. Preferably, the second partition 123 is a cylindrical partition parallel to the side wall of the reaction section 12. For example, as shown in fig. 1, the cylindrical second partition 123 is combined with the first partition 122 to form a first reaction chamber without dead space, so that the material flows more smoothly in the respective reaction chambers and the contact between the materials is more uniform.
Further, the inner diameter of the inner reaction chamber is preferably 1/4 to 1/3 of the inner diameter of the reaction section 12. So that the volumes of the inner reaction chamber and each first reaction chamber are relatively uniform, and the reactions in each reaction chamber are relatively synchronous.
In order to maintain the pressure drop in each reaction chamber of the reaction column 10 stable, it is preferable that the reaction section 12 employs a pipeline of DN10 to DN800, and the length-diameter ratio of the reaction section 12 is 0.05: 1-50: 1; preferably 0.2:1 to 20: 1.
Preferably, in the above formula, R1Represents C1-C10, preferably methyl, ethyl, tert-butyl, n-hexyl or n-heptyl. So as to reduce the synthesis difficulty of the catalyst carrier.
The supported rhodium catalyst of the present application can be prepared by using a supported rhodium catalyst of the prior art or by using a preparation method of the prior art, such as the supported rhodium catalyst disclosed in patent No. 201410459708.3 or by using a preparation method thereof.
There are various ways of carrying out the above-mentioned loop closing reaction using the above-mentioned column type continuous reactor, and it is preferable that the step S1 includes: dissolving (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3-oxopentanoate in a first organic solvent to form a first raw material solution, the first organic solvent being selected from any one or more of the group consisting of ethyl acetate, methyl acetate, tetrahydrofuran, dichloromethane, chloroform, and methyl isobutyl ketone. The first raw material liquid is formed by stirring at 10 to 40 ℃. Feeding the first raw material liquid into a column type continuous reactor, and catalyzing (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3 oxopentanoate to perform a ring-closing reaction at 30-60 ℃ by using a supported rhodium catalyst to form a first intermediate system containing a first intermediate, wherein the retention time of the first raw material liquid in the column type continuous reactor is preferably 2-40 min, and preferably 4-20 min. Preparing (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3 oxo valerate into a solution in advance, and then feeding the solution into a column type continuous reactor to facilitate the control of a ring closing reaction process. The cyclization reaction can occur at 30-60 ℃, and is greatly reduced compared with the prior art at 80-100 ℃; in addition, due to the improvement of the catalytic efficiency, the retention time of the first raw material liquid in the column type continuous reactor can be relatively shortened, for example, within the range of 2-40 min, even within the range of 4-20 min, and a higher yield of the first intermediate can be obtained.
Preferably, the content of (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3 oxopentanoate in the first raw material solution is 0.2-0.6 mmol/mL.
In another embodiment of the present application, since the temperature of the esterification reaction is low, in order to improve the preparation efficiency, it is preferable that the above step S2 includes: pre-cooling the second continuous reactor to-32-12 ℃; and respectively feeding the first intermediate system, the diphenyl chlorophosphate solution and the diisopropylethylamine solution into a pre-cooled second continuous reactor for esterification reaction to obtain a product system containing the intermediate MAP of the penem, wherein the retention time of reactants in the second continuous reactor is 2-40 min, preferably 4-20 min, and preferably, the solvent in the diphenyl chlorophosphate solution and the solvent in the diisopropylethylamine solution are respectively and independently selected from one or more of the group consisting of ethyl acetate, methyl acetate, tetrahydrofuran, dichloromethane, trichloromethane and methyl isobutyl ketone. The second continuous reactor is pre-cooled to-32-12 ℃ in advance, so that the materials can enter the second continuous reactor (PFR) to quickly enter a reaction state, and the preparation efficiency is improved.
For simplicity of operation, it is preferred that the solvent in the solution of diphenyl chlorophosphate and the solvent in the solution of diisopropylethylamine are the same as the first organic solvent in which (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3-oxopentanoate is dissolved. Preferably, the content of diphenyl chlorophosphate in the diphenyl chlorophosphate solution is 0.6-3.0 mmol/mL; the content of diisopropylethylamine in the solution of diisopropylethylamine is 0.6-3.0 mmol/mL. In order to increase the utilization rate of each substance, the flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, and the diisopropylethylamine is preferably 1: 0.5-2.0: 0.1 to 1.0: 0.1 to 1.0.
The second continuous reactor is a one-stage coil continuous reactor or a continuous reactor with a plurality of stages of coils connected in series. The continuous reactor in which the multi-stage coil pipes are connected in series can improve the production efficiency. When the coil continuous reactor is used, the applicable temperature range of the esterification reaction is wider and is easier to control, and the retention time can be relatively shortened to 2-40 min, even 4-20 min.
Before the step S2, the first intermediate system obtained in the step S1 may be collected in a receiving device such as a storage tank or an enamel kettle and pre-cooled to-12 to 25 ℃ (preferably-10 to 10 ℃), the collecting device is connected with the column type continuous reactor and the second continuous reactor, and then the reaction in the step S2 is performed after a certain amount of the first intermediate system is collected, so as to further ensure the continuity and stability of the process.
Step S3 of the present application is to separate the product MAP for crystallization, and the crystallization method applicable to the present application may be continuous crystallization or batch crystallization, and in one embodiment, the step S3 includes: sending the product system, a quenching agent and a crystallization liquid into a third continuous reactor for continuous crystallization to obtain a crystallization system, wherein the quenching agent is selected from any one or more of pure water, potassium dihydrogen phosphate buffer solution, potassium hydrogen phosphate buffer solution, sodium dihydrogen phosphate buffer solution and sodium hydrogen phosphate buffer solution, and the crystallization liquid is selected from any one or more of hexane, heptane, octane, methylcyclopentane and petroleum ether; and carrying out solid-liquid separation on the crystallization system to obtain the intermediate MAP of the penem. The buffer solution such as the potassium dihydrogen phosphate buffer solution adopts a conventional mass concentration of 2-10%.
And a continuous crystallization mode is adopted, so that the production efficiency can be improved. At the beginning of step S3, the product system and the quenching agent may be fed into the third continuous reactor to quench, and then the crystallization liquid is fed into the third continuous reactor, and during normal operation, the three are fed simultaneously, and the feeding speeds of the three may be controlled to control the quenching and crystallization effects and rates, for example, the flow ratio of the first raw material liquid, the product system, the quenching agent and the crystallization liquid is controlled to be 1: 0.7-4.0: 0.5-5.0: 0.5 to 5.0. The third continuous reactor is a one-stage coil continuous reactor or a continuous reactor with a plurality of stages of coils connected in series.
In another embodiment, the step S3 includes: sending the product system into a quenching agent for quenching, and then sending a crystallization liquid into the product system for crystallization to obtain a crystallization system, wherein the quenching agent is selected from any one or more of the group consisting of pure water, a potassium dihydrogen phosphate buffer solution, a potassium hydrogen phosphate buffer solution, a sodium dihydrogen phosphate buffer solution and a sodium hydrogen phosphate buffer solution, and the crystallization liquid is selected from any one or more of the group consisting of hexane, heptane, octane, methylcyclopentane and petroleum ether; and carrying out solid-liquid separation on the crystallization system to obtain the intermediate MAP of the penem. The batch crystallization mode is adopted, and the crystallization efficiency and the product purity are improved by adopting the mode of quenching before crystallization.
The solid-liquid separation mode in the two embodiments can be filtration, suction filtration or centrifugation, and specific operation conditions can be referred to the prior art and are not described herein again.
The advantageous effects of the present application will be further described below with reference to examples and comparative examples.
(1) Respectively dissolving (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3 oxo valerate, diphenyl chlorophosphate and diisopropylethylamine in ethyl acetate to respectively obtain a first raw material solution, a diphenyl chlorophosphate solution and a diisopropylethylamine solution; the content of the (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3 oxopentanoate solution in the first raw material liquid is 0.2-0.6 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 0.6-3.0 mmol/mL; the concentration of the diisopropylethylamine solution is 0.6-3.0 mmol/mL.
(2) Pumping the first raw material solution prepared in the step (1) into a column type continuous reactor shown in figures 1 and 2 for reaction, wherein the residence time of the column type continuous reactor is 2-40 min, the reaction temperature is 30-60 ℃, a ring-closing reaction is carried out under the catalysis of a supported rhodium catalyst to generate a first intermediate system containing a first intermediate, the first intermediate system flows out of the column type continuous reactor and enters a receiving device, the inner diameter of an inner reaction chamber of the column type continuous reactor is 1/4-1/3 of the inner diameter of a reaction section, and the length-diameter ratio of the reaction section is 0.05: 1-50: 1; preferably 0.2:1 to 20: 1.
(3) The first intermediate system is sent into a multi-stage coil type continuous reactor; and (2) simultaneously, feeding the diphenyl chlorophosphate solution and the diisopropylethylamine solution prepared in the step (1) into the multistage coiled continuous reactor, and allowing the first intermediate system, the diphenyl chlorophosphate solution and the diisopropylethylamine solution to enter the multistage coiled continuous reactor precooled to-32-12 ℃ for esterification reaction, wherein the retention time of each reactant in the multistage coiled continuous reactor is 2-40 min.
(4) Continuous crystallization: sending the product system flowing out of the multi-stage coil type continuous reactor into another multi-stage coil type continuous reactor, sending 2-10% of potassium dihydrogen phosphate buffer solution into the reactor for mixing and quenching, then sending heptane for continuous crystallization to obtain a crystallization system, and centrifugally separating the crystallization system after flowing out of the multi-stage coil type continuous reactor to finally obtain a product, namely a penem intermediate MAP ((4R,5R,6S) -3- [ (diphenyloxyphenyl) oxy ] -6- [ (1R) -1-hydroxyethenyl ] -4-methyl-7-oxo-1-azabicyclo [3.2.0] pt-2-ene-2-carboxylic acid (4-nitrophenyl) methyl ester);
or (4) batch crystallization: quenching a product system flowing out of the multistage coiled continuous reactor in a 2-10% monopotassium phosphate buffer solution prepared in advance, adding heptane into the solution for crystallization to obtain a crystallization system, and performing centrifugal separation on the crystallization system to finally obtain a product, namely a culture intermediate MAP ((4R,5R,6S) -3- [ (dioxy) oxy ] -6- [ (1R) -1-hydroxyethoxy ] -4-methyl-7-oxo-1-azabicyclo [3.2.0] pt-2-ene-2-carboxylic acid (4-nitrophenyl) methyl ester);
the flow ratio of the first raw material solution, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution, and heptane per unit time is 1: 0.5-2.0: 0.1 to 1.0: 0.1 to 1.0: 0.7-4.0: 0.5-5.0: 0.5 to 5.0.
Example 1
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 40 ℃, and the column type continuous reaction is carried outThe inner diameter of the inner reaction chamber of the reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 2
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 20min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 3
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 40min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 4
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 4min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 5
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidine-4-keto-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 30 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 6
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 60 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.25: 0.25: 1.5: 2.0: 2.5.
example 7
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-32 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 8
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-10 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. First raw material liquid, secondAn intermediate system, a diphenyl chlorophosphate solution, a diisopropylethylamine solution, a product system, a potassium dihydrogen phosphate buffer solution and heptane, wherein the flow ratio of the intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 9
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be 12 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 10
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 40 ℃, and the inner diameter of the inner reaction chamber of the column type continuous reactor is a reaction section1/3 for the inner diameter, the length to diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 40min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 11
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 20min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 12
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 4min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 13
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.6 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 3.0 mmol/mL; the solution concentration of the diisopropylethylamine is 3.0mmol/mL, and the supported rhodium catalyst isCompound 62 of patent No. 201410459708.3. The retention time of the step (1) is 40min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 40min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 14
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]Of solutions of (E) -3 oxopentanoateThe content is 0.2 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 0.6 mmol/mL; the solution concentration of the diisopropylethylamine is 0.6mmol/mL, and the supported rhodium catalyst isI.e. compound 63 of patent No. 201410459708.3. The retention time of the step (1) is 2min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 2min and controlling the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 15
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the solution concentration of the diisopropylethylamine is 2.5mmol/mL, and the supported rhodium catalyst isCompound 64 in patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 16
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.5 mmol/mL; the concentration of the diphenyl chlorophosphate solution is 2.5 mmol/mL; the concentration of diisopropylethylamine in the solution was 2.5 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.3: 0.3: 1.6: 2.5: 3.0.
example 17
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.4 mmol/mL; the concentration of the diphenyl chlorophosphate solution was 1.0 mmol/mL; the concentration of diisopropylethylamine in the solution was 1.0 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the inner diameter of the inner reaction chamber of the column type continuous reactor with the reaction temperature of 20 ℃ is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. First raw material solution, first intermediate system, diphenyl chlorophosphate solutionThe flow ratio of the solution of diisopropylethylamine, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.4: 0.4: 1.8: 1.6: 2.1.
example 18
Preparing a penem intermediate MAP by adopting the process, wherein in the step (1), in the first raw material liquid, (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl]-the content of the 3-oxopentanoate solution is 0.45 mmol/mL; the concentration of the diphenyl chlorophosphate solution was 1.1 mmol/mL; the concentration of diisopropylethylamine in the solution was 1.1 mmol/mL. The supported rhodium catalyst isCompound 61 of patent No. 201410459708.3. The retention time of the step (1) is 10min, the reaction temperature is 40 ℃, the inner diameter of the inner reaction chamber of the column type continuous reactor is 1/3 of the inner diameter of the reaction section, and the length-diameter ratio of the reaction section is 10: 1. and (2) adopting a coil pipe continuous reactor, controlling the retention time to be 10min and the reaction temperature to be-5 ℃. The concentration of the potassium dihydrogen phosphate buffer solution in the step (3) is 5%. The flow ratio of the first raw material liquid, the first intermediate system, the diphenyl chlorophosphate solution, the diisopropylethylamine solution, the product system, the potassium dihydrogen phosphate buffer solution and the heptane in unit time is 1: 1.0: 0.4: 0.4: 1.8: 1.8: 2.3.
the products of the above examples were identified and it was determined that the target product, MAP, was obtained and the yields are reported in Table 4. HPLC detection is carried out on the products obtained in each example to determine the purity and isomers, infrared test is carried out on the products to identify the structures, thermogravimetric analysis is carried out to further analyze the purity of the products, X-ray diffraction analysis is carried out to confirm the crystal structures, GC test is carried out to analyze the residual solvents in the products, wherein the HPLC test results of the purity and the isomers of the example 18 are shown in a figure 3 and a figure 4, the infrared test results are shown in a figure 5, the TG and DTG curves of the thermogravimetric analysis results are shown in a figure 6, the XRD spectrogram is shown in a figure 7, and the GC spectrogram is shown in a figure 8, wherein the data corresponding to the figure 3 are shown in a table 1.
TABLE 1
The corresponding data description of fig. 4 is shown in table 2.
TABLE 2
The corresponding data description of fig. 8 is shown in table 3.
TABLE 3
According to the test result of fig. 6, it can be seen that the weight loss is 0.011mg and the weight loss rate is 0.059% when the steel is heated to 150 ℃.
TABLE 4
Yield (%) | Yield (%) | ||
Example 1 | 87 | Example 10 | 87 |
Example 2 | 85 | Example 11 | 85 |
Example 3 | 88 | Example 12 | 86 |
Example 4 | 86 | Example 13 | 89 |
Example 5 | 87 | Example 14 | 87 |
Example 6 | 83 | Example 15 | 85 |
Example 7 | 85 | Example 16 | 86 |
Example 8 | 88 | Example 17 | 81 |
Example 9 | 85 | Example 18 | 87 |
According to the results of the above examples, it can be seen that the first step of the cyclization reaction is performed at a relatively low temperature (30-60 ℃) due to the column reactor and the supported rhodium catalyst, so that the high yield of the final product MAP can be ensured.
From the above description, it can be seen that the above-described embodiments of the present invention achieve the following technical effects:
according to the method, a column type continuous reactor is used as a place where a loop closing reaction occurs, a gaseous product is formed while a first intermediate is formed through the loop closing reaction, and the gaseous product forms a disturbance effect on a supported rhodium catalyst in the rising process of the gaseous product in the column type continuous reactor, so that the high-efficiency contact of (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3 oxopentanoate and the catalyst is facilitated, the catalytic effect is improved, and the supported rhodium catalyst has high mechanical performance and catalytic activity and is easy to recycle due to the fact that a polymer is used as a carrier. Under the synergistic effect of above-mentioned column type continuous reactor and load rhodium catalyst for the ring closing reaction of this application can high-efficiently go on under lower temperature, has reduced the difference in temperature of ring closing reaction and esterification reaction, thereby has reduced the required cold source of first midbody cooling, and then has reduced the energy consumption, is particularly useful for the industrialization and uses.
The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (10)
1. A continuous preparation method of intermediate MAP of penem is characterized by comprising the following steps:
step S1, catalyzing (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3 oxopentanoate to perform a cyclization reaction in a column type continuous reactor by using a supported rhodium catalyst to form a first intermediate, wherein the supported rhodium catalyst is loaded in the column type continuous reactor and has the following structural formula:
wherein R is1Represents any one of C1-C10 alkyl; P-COO-represents a residue of the polymer after hydrogen removal, and x represents an arbitrary number of 0.1 to 4.0;
step S2, carrying out esterification reaction on the first intermediate, diphenyl chlorophosphate and diisopropylethylamine in a second continuous reactor to obtain a product system containing a penem intermediate MAP; and
and step S3, carrying out crystallization treatment on the product system to obtain the penem intermediate MAP.
2. The continuous production method according to claim 1, wherein the column type continuous reactor comprises a reaction column, and the reaction column comprises from bottom to top:
the feeding section (11) is provided with a liquid inlet (111), and a liquid distribution device is arranged above the liquid inlet (111);
the reaction section (12) is separated from the feeding section (11) through a porous bottom plate (14), an inert filler (121) and the loaded rhodium catalyst are filled in the reaction section (12), the reaction section (12) is provided with a plurality of first partition plates (122) which are circumferentially arranged, and each first partition plate (122) extends along the vertical direction to divide the inner cavity of the reaction section (12) into a plurality of first reaction chambers;
a discharge section (13), the discharge section (13) being isolated from the reaction section (12) by a porous top plate (15), the discharge section (13) having a liquid product outlet (131) and an exhaust port (132).
3. The continuous production method according to claim 2, wherein a second partition plate (123) is further disposed in the inner cavity of the reaction section (12), the second partition plate (123) is a cylindrical partition plate disposed coaxially with the reaction column, the second partition plate (123) divides the inner cavity of the reaction section (12) into an inner reaction chamber and an outer reaction chamber, and the first partition plate (122) is disposed in the outer reaction chamber and divides the outer reaction chamber into a plurality of the first reaction chambers.
4. The continuous production method according to claim 1, wherein R in the formula1Represents C1-C10 alkyl, preferably methyl, ethyl, tert-butyl, n-hexyl or n-heptyl.
5. The continuous production method according to claim 2, wherein the step S1 includes:
dissolving the (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3 oxopentanoate in a first organic solvent selected from any one or more of the group consisting of ethyl acetate, methyl acetate, tetrahydrofuran, dichloromethane, chloroform, and methyl isobutyl ketone to form a first feedstock;
and feeding the first raw material liquid into the column type continuous reactor, and catalyzing (R) -4-nitrobenzyl-2-diazo-4- [ (2R,3S) -3- ((R) -1-hydroxyethyl) -azetidin-4-one-2-yl ] -3-oxo valerate to perform a ring-synthesizing reaction at 30-60 ℃ by using the supported rhodium catalyst to form a first intermediate system containing a first intermediate, wherein the retention time of the first raw material liquid in the column type continuous reactor is preferably 2-40 min, and preferably 4-20 min.
6. The continuous production method according to claim 1, wherein the step S2 includes:
pre-cooling the second continuous reactor to-32-12 ℃;
and (2) respectively feeding the first intermediate system, the diphenyl chlorophosphate solution and the diisopropylethylamine solution into the pre-cooled second continuous reactor for esterification to obtain a product system containing a penem intermediate MAP, wherein a solvent in the diphenyl chlorophosphate solution and a solvent in the diisopropylethylamine solution are respectively and independently selected from any one or more of ethyl acetate, methyl acetate, tetrahydrofuran, dichloromethane, chloroform and methyl isobutyl ketone, preferably before step S2, collecting the first intermediate system obtained in step S1 into a receiving device, pre-cooling the first intermediate system to-12-25 ℃, and connecting the collecting device with the column type continuous reactor and the second continuous reactor.
7. The continuous preparation method according to claim 1, wherein the second continuous reactor is a one-stage coil continuous reactor or a multi-stage coil continuous reactor in series, and the retention time of the reactants in the second continuous reactor is 2-40 min, preferably 4-20 min.
8. The continuous production method according to claim 1, wherein the step S3 includes:
sending the product system, a quenching agent and a crystallization liquid into a third continuous reactor for continuous crystallization to obtain a crystallization system, wherein the quenching agent is selected from any one or more of pure water, potassium dihydrogen phosphate buffer solution, potassium hydrogen phosphate buffer solution, sodium dihydrogen phosphate buffer solution and sodium hydrogen phosphate buffer solution, and the crystallization liquid is selected from any one or more of hexane, heptane, octane, methylcyclopentane and petroleum ether;
and carrying out solid-liquid separation on the crystallization system to obtain the intermediate MAP of the penem.
9. The continuous production method according to claim 8, wherein the third continuous reactor is a one-stage coil continuous reactor or a multi-stage coil continuous reactor in series.
10. The continuous production method according to claim 1, wherein the step S3 includes:
sending the product system into a quenching agent for quenching, and then sending a crystallization liquid into the product system for crystallization to obtain a crystallization system, wherein the quenching agent is selected from any one or more of the group consisting of pure water, a potassium dihydrogen phosphate buffer solution, a potassium hydrogen phosphate buffer solution, a sodium dihydrogen phosphate buffer solution and a sodium hydrogen phosphate buffer solution, and the crystallization liquid is selected from any one or more of the group consisting of hexane, heptane, octane, methylcyclopentane and petroleum ether;
and carrying out solid-liquid separation on the crystallization system to obtain the intermediate MAP of the penem.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911033478.3A CN110790790A (en) | 2019-10-28 | 2019-10-28 | Continuous preparation method of penem intermediate MAP |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911033478.3A CN110790790A (en) | 2019-10-28 | 2019-10-28 | Continuous preparation method of penem intermediate MAP |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110790790A true CN110790790A (en) | 2020-02-14 |
Family
ID=69441607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911033478.3A Pending CN110790790A (en) | 2019-10-28 | 2019-10-28 | Continuous preparation method of penem intermediate MAP |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110790790A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021081714A1 (en) * | 2019-10-28 | 2021-05-06 | 吉林凯莱英制药有限公司 | Method for continuously preparing map penem intermediate |
WO2022041462A1 (en) * | 2020-08-25 | 2022-03-03 | 凯莱英生命科学技术(天津)有限公司 | Synthesis method for cyclopropane compound |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104262523A (en) * | 2013-11-29 | 2015-01-07 | 凯莱英医药集团(天津)股份有限公司 | Carboxyl-containing polymer, preparation method and application thereof, as well as preparation method of supported catalyst and imipenem antibiotic intermediate |
CN108948086A (en) * | 2018-08-22 | 2018-12-07 | 浙江海翔川南药业有限公司 | Train the synthesis technology and process system of southern class antibiotic parent nucleus MAP |
CN109876747A (en) * | 2019-04-02 | 2019-06-14 | 吉林凯莱英医药化学有限公司 | Pillar flow reactor and pillar continuous reaction system |
-
2019
- 2019-10-28 CN CN201911033478.3A patent/CN110790790A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104262523A (en) * | 2013-11-29 | 2015-01-07 | 凯莱英医药集团(天津)股份有限公司 | Carboxyl-containing polymer, preparation method and application thereof, as well as preparation method of supported catalyst and imipenem antibiotic intermediate |
CN108948086A (en) * | 2018-08-22 | 2018-12-07 | 浙江海翔川南药业有限公司 | Train the synthesis technology and process system of southern class antibiotic parent nucleus MAP |
CN109876747A (en) * | 2019-04-02 | 2019-06-14 | 吉林凯莱英医药化学有限公司 | Pillar flow reactor and pillar continuous reaction system |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021081714A1 (en) * | 2019-10-28 | 2021-05-06 | 吉林凯莱英制药有限公司 | Method for continuously preparing map penem intermediate |
WO2022041462A1 (en) * | 2020-08-25 | 2022-03-03 | 凯莱英生命科学技术(天津)有限公司 | Synthesis method for cyclopropane compound |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110790790A (en) | Continuous preparation method of penem intermediate MAP | |
CN108948086B (en) | Synthetic process and process system of mother nucleus MAP of penem antibiotics | |
CN111484537B (en) | Method for preparing Rudesiwei key intermediate by using microchannel reaction device | |
CN112812107B (en) | Preparation method of SGLT-2 inhibitor and intermediate | |
CN111100088B (en) | Method for continuously synthesizing ethyl dithiahydroxamate | |
JP7383812B2 (en) | Continuous production method of penem intermediate MAP | |
CN103864748A (en) | Purification method of 4-chloromethyl-5-methyl-1,3-dioxole-2-ketone | |
CN108752338A (en) | A kind of preparation method of 1,2,3 full substitution Indoli zine derivatives | |
JP2023512020A (en) | Continuous flow process for the preparation of acephate and its intermediates | |
CN102702201B (en) | Doripenem intermediate compound, preparation method and application of doripenem intermediate compound and preparation method for doripenem | |
CN114746397A (en) | Continuous flow process for the synthesis of hydroxamic acids | |
CN101417982B (en) | Synthesis of 4-ethyl-(2,3-dioxo piperazinyl)formyl chloride-1 and preparation of crystal thereof | |
CN101735220B (en) | Crystal form of 6, 7-dihydro-6-mercapto-5H-pyrazolo[1,2-alpha][1,2,4] triazoliumchloride and preparation method thereof | |
CN114230447B (en) | Continuous flow preparation method of 4' -fluoro-2-phenyl acetophenone | |
CN114181115A (en) | Salifying system, salifying process and preparation process of trimethyl orthoacetate | |
CN111559968B (en) | Preparation method of lacosamide crystal form II | |
CN114933611A (en) | Method for continuously preparing penem antibiotic intermediate 4-acetoxy azetidinone | |
CN109456376B (en) | Novel preparation method of nucleoside modifier 5 '-DMTr-2' -EOE-5-Me-cytosine nucleoside | |
CN109293677B (en) | Continuous production method and device of 7-amino-3-vinyl cephalosporanic acid | |
CN110845540A (en) | Preparation method and preparation device of hexaphenoxycyclotriphosphazene | |
CN112125913A (en) | Synthesis method of high-purity ibrutinib | |
CN112125957B (en) | Preparation method of caspofungin acetate | |
CN116986558A (en) | Production process of high-purity sodium azide | |
CN110066301A (en) | A kind of synthetic method of clindamycin phosphate | |
CN110759947A (en) | Synthesis method of hexaphenoxycyclotriphosphazene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200214 |